Nazol (Naphazoline Nitrate)

Naphazoline nitrate, the active ingredient in Nazol, is an alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It provides rapid relief of nasal congestion and reduces swelling of the nasal mucosa in adults and children over two years of age.

GNH USA supplies Nazol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Nazol, an alpha‑adrenergic nasal decongestant, is indicated for conditions involving nasal airway obstruction.

- Nasal congestion: rapid alleviation of blocked nasal passages - Allergic rhinitis: reduction of mucosal swelling and improved airflow - Acute sinusitis: relief of congestion associated with sinus inflammation

Naphazoline nitrate may cause local and systemic adverse reactions, which are classified by frequency.

Common Side Effects: - Nasal burning or stinging - Dryness of nasal mucosa - Sneezing - Mild headache - Transient nasal irritation

Serious or Rare Side Effects: - Severe hypertension - Cardiac arrhythmia - Allergic reaction (rash, swelling, anaphylaxis) - Nasal ulceration or perforation - Rebound congestion (rhinitis medicamentosa)

When using Nazol, consider the following precautions to minimize risk.

- Pregnancy: safety not established; consult a healthcare professional before use - Elderly: use with caution due to increased cardiovascular sensitivity - Duration of use: limit to 3‑5 days to avoid rebound congestion - Concurrent MAO inhibitors: may increase hypertensive response - Store at room temperature: keep container tightly closed, protect from light and moisture

Nazol can interact with other agents that affect the cardiovascular or adrenergic systems.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis - Sympathomimetic decongestants: additive vasoconstriction - Beta‑blockers: may mask tachycardia

Moderate Interactions (Monitor Closely):\n- Antihypertensive agents: may reduce efficacy of blood‑pressure control - Tricyclic antidepressants: potential increase in blood pressure - Cocaine: additive vasoconstrictive effects